210
S.Bhagatetal./InternationalJournalofSurgery11(2013)209e217
hasbeenusedforreducingin ammation.1e7Entericcoatedoralformulationofthisenzymeisbeingusedcommonlyinvariousspecialitieslikesurgery,orthopaedics,otolaryngology,gynaecologyanddentistryforitsanti-in ammatoryandanti-edemicproperties.Theuseofenzymesliketrypsin,8chymotrypsin,9bromelain10asanti-in ammatoryagentscameintopracticeafteritwasobservedduring1950sinUSAthatparenteraltrypsincouldbeusedtorelievepost-surgicalin ammationandthatduetotraumaticinjurycausedbysports8aswellasin ammationduetoconditionslikerheu-matoidarthritis,ulcerativecolitis,andatypicalviralpneumonia.
ThisobservationwassoonfollowedbytheuseofSerratio-peptidase2foritsanti-in ammatoryeffectsinJapanforthe rsttime.Laterduring1960stheseparenteralenzymeformulationswerereplacedbytheirentericcoatedsuccessorstobeusedorally.During1980sand1990sitwasproposedbyseparateresearchconductedinEuropeandJapanthatSerratiopeptidasewasthemosteffectiveagentinreducingin ammationamongallotherenzymepreparations.1,3Serratiopeptidasehence,hasbeenusedforalmost40yearsinJapanandEuropeforpainandin ammationduetoarthritis,trauma,surgery,sinusitis,bronchitis,carpaltunnelsyn-dromeandpainfulswellingofbreasts.Apartfromitsanti-in ammatoryactivity,Serratiopeptidaseisalsosaidtopossessanalgesicandanti-atheroscleroticeffects.Thissystematicreviewisanattempttocriticallyexaminetheavailableevidencewhichexistsasregardstheef cacyandsafetyofSerratiopeptidase.2.Evidenceacquisition2.1.Searchcriteria
Toidentifyarticles,wesystematicallysearchedelectronicda-tabasesandcommercialwebsitesforpublishedandunpublishedstudies,appliedinclusioncriteriaandperformedqualityappraisals.ThedatabasessearchedincludetheCochraneLibrary,PubMed,MEDLINE,theControlledtrialsregistryClinicalTrials.gov,Google,Dogpile.AmanualsearchfromreferencelistsofrelevantarticleswasconductedandPharmaceuticalcompanieswerecontactedthroughemailsforadditionalinformationonpharmacokinetics,pharmacodynamics,ef cacyandsafetyofSerratiopeptidase.The
followingsearchtermswereusedeitherindependentlyofeachotherorincombinations:Serratiopeptidase,serrapeptase,serra-tiopeptidase,proteolyticenzymes,pharmacokinetics,pharmaco-dynamics,anti-in ammatoryagents,danzen,serratiapeptase,serralysin,adversedrugreactions.2.2.Inclusioncriteria
EligiblestudieswererequiredtoreportresultsonSerratio-peptidaseef cacyandsafety.Allarticlesavailableonef cacywereincluded.Allarticleswererequiredtobecompleteandavailableinenglish.Studieswereselectedforinclusioninoursystematicre-viewiftheymettheinclusioncriteria:double-blind,single-blind,openlabel,placebo-controlled,randomisedcontrolledtrials,meta-analysisofRCTs,prospectivetrialsorpreclinicalstudies.
Atotalof24studiesonclinicalef cacyofSerratiopeptidasemettheinclusioncriteria.Amongwhich18wereclinicaltrials(including14RCTs,3prospectivetrialsandin1trialstudydesignnotstated)and6werepreclinicalanimalstudies.AsSerratio-peptidasehasbeeninclinicaluseforin ammationandpainforanumberofyearsandisbeingpromotedthesedaysforitsanti-atheroscleroticeffectsalso.Butdataonitsanalgesicandanti-atheroscleroticef cacywasfoundtobelacking.TheRCTswereonlyafewinnumbers(14RCTsintotalexcludingtheduplicatedstudies,11RCTsfoundonCochraneLibraryand9onPubMedsearch).Theyhadalimitedpopulation,notmorethan150patientspergroupinanyofthestudiesandwereofshortduration.Thereforeprospectivestudiesaswellaspreclinicalstudieswerealsoincludedtoappraiseevidenceonef cacyofSerratiopeptidase.2.3.Qualityappraisal
CriticalappraisalofstudieswasconductedusingPRISMA11statement(Fig.1)whiletheScottishIntercollegiateGuidelinesNetwork(SIGN)12gradingforRCTswasusedfororiginalstudiesbytwoseparatereviewersandthencoordinatedtogethertovalidatethe nalgrading.Thiswasdonetofacilitatetransparentandcomprehensivereportingofresults.Anydisagreementbetweenthetworeviewerswasresolvedbydiscussionwiththethird

reviewer.
Fig.1.Preferredreportingitemsforsystematicreviewsandmeta-analysis(PRISMA)11 owdiagramofstudiesincludedinthereviewofef cacyofserratiopeptidase.
evidence in making decisions about the care of individual?patients.(Sackett,?DL)? ? A systematic review is a comprehensive study of A?systematic?review?...
The_Level_of_Evidence_Pyramid__Indicating_Levels.47_临床医学_医药卫生_专业...a systematic review of these studies Case-control study; or any of the ...
-aventis Second edition Evidence-based medicine What is a systematic review?...existing agendas have failed to address a clinical problem G Increasingly ...
(Lepidium meyenii) for treatment of menopausal symptoms A systematic review_... a qualitative review and opted for a synthesis of the best evidence. ...
A Systematic Review of Xuezhikang, for Coronary Heart Disease Complicated by... Hindawi Publishing Corporation Evidence-Based Complementary and Alternative ...
of Findings table for a Cochrane systematic review_经济学_高等教育_教育专区...GRADE of the quality of evidence (last column and footnotes of the SoF)...
provide stronger evidence than a ‘higher level’ study – say a systematic review of few studies leading to an inconclusive result (see Background ...
we performed a systematic review and meta-analysis of the current evidence for the association between ALA exposure, including studies of dietary ALA and ...
systematic reniew and meta-analysis of the effects of high protein oral ...The systematic review and meta-analysis provides evidence that high protein ...
It may provide bene?ts and clinical evidence for both patients and clinicians. Although a related systematic review has been published by Hao and ...
热门文档